Inventor · disambiguated record
Chen-Yong Lin
Also filed as: LIN CHEN · LIN CHEN-YONG
13 granted patents·7 pending applications·58 citations·filing 1997–2024
88Inventor score
Files withUNIV RUTGERS10GEORGETOWN UNIVERSITY SCHOOL O2TAIWAN SEMICONDUCTOR MFG2UNIV GEORGETOWN2GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE1
Top patents by PatentIndex Score
20 records- 0187US7355015B1Matriptase, a serine protease and its applicationsGEORGETOWN UNIVERSITY SCHOOL O·Filed 2000·Granted Apr 8, 2008·27 cites·7 claims
- 0283US2025011470A1Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2024·Application pending·0 cites
- 0380US10376597B2Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2017·Granted Aug 13, 2019·1 cites·10 claims
- 0478US9849192B2Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2016·Granted Dec 26, 2017·1 cites·3 claims
- 0575US2024245801A1Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moietiesUNIV RUTGERS·Filed 2023·Application pending·0 cites
- 0674US6677377B2Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditionsGEORGETOWN UNIVERSITY SCHOOL O·Filed 2001·Granted Jan 13, 2004·15 cites·23 claims
- 0772US2019358340A1Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2019·Application pending·0 cites
- 0871US2021177985A1Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2021·Application pending·0 cites
- 0967US11752215B2Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moietiesUNIV RUTGERS·Filed 2021·Granted Sep 12, 2023·0 cites·9 claims
- 1055US7960163B2Matriptase, a serine protease and its applicationsGEORGETOWN UNIVERSITY SCHOOL OF MEDICINE·Filed 2008·Granted Jun 14, 2011·0 cites·3 claims
- 1154US9549993B2Specific delivery of toxins conjugated with antibodies to activate matripaseUNIV RUTGERS·Filed 2013·Granted Jan 24, 2017·0 cites·11 claims
- 1253US6077938AMonoclonal antibody to an 80 kda proteaseUNIV GEORGETOWN·Filed 1997·Granted Jun 20, 2000·7 cites·9 claims
- 1351US9682094B2Targeting matriptase expressing tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2015·Granted Jun 20, 2017·0 cites·13 claims
- 1450US7037776B2Single polysilicon process for DRAMTAIWAN SEMICONDUCTOR MFG·Filed 2002·Granted May 2, 2006·4 cites·45 claims
- 1549US2019151464A1Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moietiesUNIV RUTGERS·Filed 2017·Application pending·0 cites
- 1647US10175238B2Markers for abnormal cellsUNIV GEORGETOWN·Filed 2015·Granted Jan 8, 2019·0 cites·23 claims
- 1746US6338998B1Embedded DRAM fabrication method providing enhanced embedded DRAM performanceTAIWAN SEMICONDUCTOR MFG·Filed 2000·Granted Jan 15, 2002·3 cites·11 claims
- 1839US2003170245A1Activation of matriptase and diagnostic and therapeutic methods based thereonFiled 2002·Application pending·0 cites
- 1938US2012294800A1Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesLIN SIANG-YO·Filed 2010·Application pending·0 cites
- 2030US8133873B2Recombinant chemokine-antigen vaccineZHANG SHUREN·Filed 2005·Granted Mar 13, 2012·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →